These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12757777)
1. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits. Tranholm M; Rojkjaer R; Pyke C; Kristensen AT; Klitgaard B; Lollike K; Blajchman MA Thromb Res; 2003 Feb; 109(4):217-23. PubMed ID: 12757777 [TBL] [Abstract][Full Text] [Related]
2. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa? Poon MC Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145 [TBL] [Abstract][Full Text] [Related]
3. rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Lauritzen B; Tranholm M; Ezban M J Thromb Haemost; 2009 Apr; 7(4):651-7. PubMed ID: 19175492 [TBL] [Abstract][Full Text] [Related]
4. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation. Gerotziafas GT; Zervas K; Arzoglou P; Karavaggeli E; Parashou S; Van Dreden P; Christakis J; Samama MM Br J Haematol; 2002 Jun; 117(3):705-8. PubMed ID: 12028045 [TBL] [Abstract][Full Text] [Related]
5. Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine. Pusateri AE; Ryan KL; Delgado AV; Martinez RS; Uscilowicz JM; Cortez DS; Martinowitz U Thromb Haemost; 2005 Feb; 93(2):275-83. PubMed ID: 15711743 [TBL] [Abstract][Full Text] [Related]
7. To general haemostasis--the evidence-based route. Erhardtsen E Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148 [TBL] [Abstract][Full Text] [Related]
8. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII? Kessler C Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091 [TBL] [Abstract][Full Text] [Related]
9. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728 [TBL] [Abstract][Full Text] [Related]
10. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation. Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259 [TBL] [Abstract][Full Text] [Related]
11. Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia. Tonda R; Galán AM; Mazzara R; White JG; Ordinas A; Escolar G Semin Hematol; 2004 Jan; 41(1 Suppl 1):157-62. PubMed ID: 14872437 [TBL] [Abstract][Full Text] [Related]
12. Potential role of recombinant factor VIIa as a hemostatic agent. Hedner U; Erhardtsen E Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390 [TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro. Kjalke M; Johannessen M; Hedner U Semin Hematol; 2001 Oct; 38(4 Suppl 12):15-20. PubMed ID: 11735105 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model. Godier A; Miclot A; Le Bonniec B; Durand M; Fischer AM; Emmerich J; Marchand-Leroux C; Lecompte T; Samama CM Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412 [TBL] [Abstract][Full Text] [Related]
15. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa. Wegert W; Harder S; Bassus S; Kirchmaier CM Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896 [TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358 [TBL] [Abstract][Full Text] [Related]
17. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa? Laurian Y Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146 [TBL] [Abstract][Full Text] [Related]
18. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Gerotziafas GT; Zervas C; Gavrielidis G; Tokmaktsis A; Hatjiharissi E; Papaioannou M; Lazaridou A; Constantinou N; Samama MM; Christakis J Am J Hematol; 2002 Mar; 69(3):219-22. PubMed ID: 11891811 [TBL] [Abstract][Full Text] [Related]
19. Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin. Chan S; Kong M; Minning DM; Hedner U; Marder VJ J Thromb Haemost; 2003 Apr; 1(4):760-5. PubMed ID: 12871413 [TBL] [Abstract][Full Text] [Related]
20. Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor. Elg M; Carlsson S; Gustafsson D Thromb Res; 2001 Feb; 101(3):145-57. PubMed ID: 11228338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]